Biosimilars Are Being Approved but Not Reaching the Market
Just halfway through the year, and 2019 has been busy for biosimilars with new guidance and approvals, but the loss of a big advocate of biosimilars from the FDA. In this episode of Managed Care Cast, Kelly Davio, senior editor of The Center for Biosimilars\xae, a sister site of\xa0The American Journal of Managed Care\xae, discusses new approvals, what the loss of Scott Gottlieb, MD, as FDA commissioner means, the reality of pay-for-delay deals, and more.\n\nLearn more about biosimilars at centerforbiosimilars.com.